Male and female patients had different outcomes, but before recommendations can be made, trials only in women are needed.

One fellow felt CV training lacked a key element—practicing the chaos of a night on call—so he created a program from scratch.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

These randomized results are encouraging, although the field awaits longer-term data to see how the leads hold up.

TMAO, produced in the gut when red meat and high-fat dairy are broken down, identified patients with rapidly growing AAAs.

Yet 44% of the high-risk patients, from LAAO’s early era, died by 5 years—researchers say this knowledge can aid ...

With so many options available for addressing the disease, it shouldn’t be accepted as inevitable, a scientific statement ...

Longer-term studies will be needed to track whether per-patient costs might drop over time with continued use of the meds.

New US hypertension guidelines, the first since 2017, released today reinforce prior recommendations that prioritize lowering ...

Japanese registry data point to fewer deaths and heart failure hospitalizations, especially when MR is reduced to mild or ...

Effects are more modest in placebo-controlled versus nonrandomized studies, with experts calling for further research.

Transcatheter devices are new to the heart failure (HF) community and treatment armamentarium for severe MR. This discussion focuses on the impact of transcatheter devices on HF patients and current ...